Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q15166
UPID:
PON3_HUMAN
Alternative names:
-
Alternative UPACC:
Q15166; A4D1H8; O75855; O76060; Q6IRU9; Q8IX97; Q9BZH9
Background:
Serum paraoxonase/lactonase 3, encoded by the gene with accession number Q15166, exhibits enzymatic activity towards a variety of substrates, including organophosphates and aromatic carboxylic acid esters. It is particularly effective in hydrolyzing lactones, such as those found in statin prodrugs like lovastatin, as well as aromatic lactones and certain ring lactones with aliphatic substituents.
Therapeutic significance:
Understanding the role of Serum paraoxonase/lactonase 3 could open doors to potential therapeutic strategies. Its ability to hydrolyze various lactones, including statin prodrugs, suggests a potential role in modulating drug efficacy and metabolism, which could be pivotal in the development of treatments for cardiovascular diseases and beyond.